321 related articles for article (PubMed ID: 8510918)
1. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
Madden SL; Cook DM; Rauscher FJ
Oncogene; 1993 Jul; 8(7):1713-20. PubMed ID: 8510918
[TBL] [Abstract][Full Text] [Related]
2. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
Sakamoto Y; Yoshida M; Semba K; Hunter T
Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
[TBL] [Abstract][Full Text] [Related]
4. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
[TBL] [Abstract][Full Text] [Related]
6. WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein.
Wang ZY; Qiu QQ; Gurrieri M; Huang J; Deuel TF
Oncogene; 1995 Mar; 10(6):1243-7. PubMed ID: 7700651
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.
Wang ZY; Qiu QQ; Deuel TF
J Biol Chem; 1993 May; 268(13):9172-5. PubMed ID: 8486616
[TBL] [Abstract][Full Text] [Related]
10. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
11. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene.
Wang ZY; Madden SL; Deuel TF; Rauscher FJ
J Biol Chem; 1992 Nov; 267(31):21999-2002. PubMed ID: 1429549
[TBL] [Abstract][Full Text] [Related]
12. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor.
Lee TH; Lwu S; Kim J; Pelletier J
J Biol Chem; 2002 Nov; 277(47):44826-37. PubMed ID: 12239212
[TBL] [Abstract][Full Text] [Related]
14. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
15. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
16. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
Lee TH; Moffett P; Pelletier J
Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
[TBL] [Abstract][Full Text] [Related]
17. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
[TBL] [Abstract][Full Text] [Related]
19. Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation.
Ghosh AK; Steele R; Ray RB
Mol Cell Biol; 1999 Apr; 19(4):2880-6. PubMed ID: 10082554
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
